BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 7578992)

  • 1. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
    Hochman PS; Majeau GR; Mackay F; Browning JL
    J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
    Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
    J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
    Matsumoto M
    J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphotoxin and LIGHT signaling pathways and target genes.
    Schneider K; Potter KG; Ware CF
    Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
    Mackay F; Majeau GR; Lawton P; Hochman PS; Browning JL
    Eur J Immunol; 1997 Aug; 27(8):2033-42. PubMed ID: 9295042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
    Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA
    J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].
    Higashi N
    Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF receptor-associated factor-2 is involved in both IL-1 beta and TNF-alpha signaling cascades leading to NF-kappa B activation and IL-8 expression in human intestinal epithelial cells.
    Jobin C; Holt L; Bradham CA; Streetz K; Brenner DA; Sartor RB
    J Immunol; 1999 Apr; 162(8):4447-54. PubMed ID: 10201981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family.
    Wallach D; Boldin M; Goncharov T; Goltsev Y; Mett I; Malinin N; Adar R; Kovalenko A; Varfolomeev E
    Behring Inst Mitt; 1996 Oct; (97):144-55. PubMed ID: 8950472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.